Authors
Loading...
In vitro study demonstrates potent inhibition of metabolic enzymes by bromophenol derivatives, suggesting their potential as multi-target antidiabetic agents.
Demir et al. (2018) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: